CD19 and systemic lupus erythematosus: In one study, eight patients received CD19-directed CAR T cells, resulting in complete SLE remission and the maintenance of a Disease Activity Index (SLEDAI) of 0 without immunosuppressive drugs at the three-month follow-up [33].